Literature DB >> 2789212

Effective cooling allows sonication to be used for liberation of beta-lactamases from gram negative bacteria.

K Bush, S B Singer.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2789212     DOI： 10.1093/jac/24.1.82

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  24 in total

1.  Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate.

Authors:  A M Queenan; S Jenkins; K Bush
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Authors:  Jesús Rodríguez-Baño; Maria Dolores Navarro; Luisa Romero; Luis Martínez-Martínez; Miguel A Muniain; Evelio J Perea; Ramón Pérez-Cano; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase.

Authors:  Kerry J Welsh; Miriam Barlow; Fred C Tenover; James W Biddle; J Kamile Rasheed; Leigh Ann Clark; John E McGowan
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.

Authors:  Anne Marie Queenan; Wenchi Shang; Paul Schreckenberger; Karen Lolans; Karen Bush; John Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

5.  Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.

Authors:  C D Steward; J K Rasheed; S K Hubert; J W Biddle; P M Raney; G J Anderson; P P Williams; K L Brittain; A Oliver; J E McGowan; F C Tenover
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

6.  SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.

Authors:  P A Bradford; C Urban; A Jaiswal; N Mariano; B A Rasmussen; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

7.  Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae.

Authors:  C Urban; K S Meyer; N Mariano; J J Rahal; R Flamm; B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

8.  Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.

Authors:  P A Bradford; C E Cherubin; V Idemyor; B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.

Authors:  Fred C Tenover; Patti M Raney; Portia P Williams; J Kamile Rasheed; James W Biddle; Antonio Oliver; Scott K Fridkin; Laura Jevitt; John E McGowan
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.

Authors:  K Bush; R K Flamm; S Ohringer; S B Singer; R Summerill; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.